To efficiently establish a persistent infection, Kaposi's sarcoma-associated herpesvirus
(KSHV; also known as HHV8) dedicates a large amount of its coding potential to produce …

MicroRNAs (miRNAs) are a class of∼ 22-nucleotide noncoding RNAs that inhibit the
expression of specific target genes at the posttranscriptional level. Recently, 11 miRNAs …

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with Kaposi's sarcoma (KS),
primary effusion lymphoma (PEL), and multicentric Castleman's disease. Most KS tumor …

Kaposi's sarcoma-associated herpesvirus (KSHV) is a B-lymphotropic herpesvirus strongly
linked to both lymphoproliferative diseases and Kaposi's sarcoma. The viral latency program …

MicroRNAs (miRNAs), which can be expressed in a cell-type and tissue-specific manner,
can influence the activities of genes that control cell growth and differentiation. Viruses often …

Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several human
cancers, including Kaposi's sarcoma, primary effusion lymphoma and multicentric …

MicroRNAs (miRNAs) are a class of small RNAs that have recently been recognized as
major regulators of gene expression. They influence diverse cellular processes ranging from …

Latency-associated nuclear antigen (LANA) encoded by open reading frame 73 (ORF73) is
the major latent protein expressed in all forms of KSHV-associated malignancies. LANA is a …

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with several different human
malignancies, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric …

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 11 distinct microRNAs, all of
which are found clustered within the major latency-associated region of the KSHV genome …